This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abel, G. A. Articles by Lynch, T. J. Search for Related Content PubMed PubMed Citation Articles by Abel, G. A. Articles by Lynch, T. J., Jr.

Schwartz Center Rounds

Direct-to-Consumer Advertising in Oncology

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Key Words. Cancer • Support • Psychosocial • Personal • Communication • Connection

Correspondence: Richard T. Penson, M.R.C.P., M.D., Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9066, Boston, Massachusetts, 02114-2617, USA. Telephone: 617-726-5867; Fax: 617-724-6898; e-mail: rpenson{at}partners.org

Shortly before his death in 1995, Kenneth B. Schwartz, a cancer patient at Massachusetts General Hospital (MGH), founded The Kenneth B. Schwartz Center at MGH. The Schwartz Center is a nonprofit organization dedicated to supporting and advancing compassionate health care delivery, which provides hope to patients and support to caregivers while encouraging the healing process. The center sponsors the Schwartz Center Rounds, a monthly multidisciplinary forum in which caregivers reflect on important psychosocial issues faced by patients, their families, and their caregivers, and gain insight and support from fellow staff members. Increasingly, cancer patients are subjected to advertisements related to oncologic therapies and other cancer-related products in the popular media. Such direct-to-consumer advertising is controversial: while it may inform, educate, and perhaps even empower patients, it also has the ability to misinform patients, and strain their relationships with oncology providers. The U.S. Food and Drug Administration requires that direct-to-consumer advertising provide a balanced presentation of a product’s benefits, risks, and side effects, but this can be difficult to achieve. Through a discussion of this topic by an oncology fellow, ethicist, cancer survivor, and senior oncologist, the role of direct-to-consumer advertising and its often subtle effects on clinical practice in oncology are explored. Although sparse, the medical literature on this increasingly prevalent type of medical communication is also reviewed.

This article has been cited by other articles:

				G. A. Abel, S. J. Lee, and J. C. Weeks Direct-to-Consumer Advertising in Oncology: A Content Analysis of Print Media J. Clin. Oncol., April 1, 2007; 25(10): 1267 - 1271. [Abstract] [Full Text] [PDF]

				R. Jagsi Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising J. Clin. Oncol., March 1, 2007; 25(7): 902 - 905. [Full Text] [PDF]